Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (4'-ethyl-2-methyl-3-piperidino)propiophenone
2. 4-empp
3. E-0646
1. 64840-90-0
2. 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one
3. Eperisone [inn]
4. 4'-ethyl-2-methyl-3-piperidinopropiophenone
5. 1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one
6. 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-1-propanone
7. Chebi:77070
8. Eperisone (inn)
9. 2m2p0551d3
10. (+-)-eperisone
11. Eperisonum
12. Eperisona
13. Eperisonum [inn-latin]
14. Eperisona [inn-spanish]
15. Ncgc00167973-01
16. Brn 1246496
17. Unii-2m2p0551d3
18. Eperisone [jan]
19. Eperisone [mi]
20. Eperisone [who-dd]
21. Schembl194769
22. Chembl1902981
23. Dtxsid5040671
24. 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-
25. Akos015960753
26. Db08992
27. Ac-12144
28. Db-054734
29. Hy-128891
30. Cs-0101898
31. Ft-0630750
32. D07898
33. 840e900
34. Q426401
35. Brd-a04252265-001-01-8
36. (2rs)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one
| Molecular Weight | 259.4 g/mol |
|---|---|
| Molecular Formula | C17H25NO |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 259.193614421 g/mol |
| Monoisotopic Mass | 259.193614421 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 275 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
M - Musculo-skeletal system
M03 - Muscle relaxants
M03B - Muscle relaxants, centrally acting agents
M03BX - Other centrally acting agents
M03BX09 - Eperisone
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]JDMF
Japanese Pharmacopoeia Eperisone Hydrochloride (for manufacturing only)
Registration Number : 218MF10690
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2006-08-11
Latest Date of Registration : 2006-08-11
Japanese Pharmacopoeia Eperisone Hydrochloride (for manufacturing only)
Registration Number : 218MF10699
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2006-08-11
Latest Date of Registration : 2013-03-27
Japanese Pharmacopoeia Eperisone Hydrochloride
Registration Number : 219MF10277
Registrant's Address : SOUTH WUSONJIANG BRIDGE, KUNNAN ROAD, ZHANGPU DISTRICT, KUNSHAN, JIANGSU PROVINCE, CH...
Initial Date of Registration : 2007-09-04
Latest Date of Registration : 2007-09-04
Registration Number : 217MF10709
Registrant's Address : 1-10-11 Nihonbashi Horidomecho, Chuo-ku, Tokyo
Initial Date of Registration : 2005-10-07
Latest Date of Registration : 2007-06-08
Registration Number : 221MF10236
Registrant's Address : No. 168 Kai-Yuan Rd. , Hsin-Ying Tainan City, 73055. Taiwan
Initial Date of Registration : 2009-10-29
Latest Date of Registration : 2019-05-31
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
